Myriad Genetics
  • Patients
    • I need help with…
      • Understanding hereditary cancer riskWhat is my risk of developing hereditary cancer?
      • Treating cancerWhat are my treatment options?
      • Guiding prenatal careAm I having a boy or girl?
        • Is my baby at risk for a genetic condition?
      • Managing mental healthHow might my genes affect my medication outcomes?
    • (sidebar parent)
      • About genetic testing
        • Affordability
        • Financial assistance
      • Patient Resources
        • How does genetic testing work?
        • Patient record request
        • Blood draw locator
        • Blog
      • Prostate Cancer
        • What are my treatment options?
  • Providers
    • My patient needs a test for…
      • Assessing hereditary cancer riskWhat is my patient’s risk of developing hereditary cancer?
      • Cancer treatmentWhat is the best treatment for my patient?
      • Prenatal careWhat is the predicted fetal sex of my patient’s baby?
        • What is a pregnancy’s risk of a genetic disease?
      • Mental health treatmentHow will my patient metabolize or respond to certain medications?
    • (sidebar parent)
      • About our tests
        • Myriad test catalog
        • Scientific Publications
        • MyRisk® gene table
        • Affordability
        • Financial assistance
        • EMR Integrations
      • Provider resources
        • Order a test kit
        • Order patient materials
        • Documents & forms
        • Scope of service & lab certificates
        • Provider portal
        • Blood draw locator
        • Blog
      • Prostate Cancer Treatment
        • What are my patient’s treatment options?
  • Biopharma
  • Our Tests
    • Tests for…
      • (column wrapper)
        • Prenatal care
          • Fetal sex
          • Chromosome conditions
          • Genetic diseases
        • Cancer risk assessment
          • Hereditary cancer
        • Mental health
          • Depression
          • Anxiety
          • ADHD
      • (column wrapper)
        • Cancer management
          • Breast cancer
          • Ovarian cancer
          • Pancreatic cancer
          • Prostate cancer
          • Endometrial cancer
          • Other cancers
          • All tests
    • (sidebar parent)
      • TESTS BY SPECIALTY
        • Oncology
        • Urology
        • Imaging
        • OB/GYN
        • Mental Health
        • Internal/Primary care
        • All tests
      • TESTS BY NAME
        • BRACAnalysis CDx®
        • EndoPredict®
        • Foresight®
        • GeneSight®
        • MyChoice® CDx
        • MyRisk® (cancer treatment)
        • MyRisk® (cancer risk)
        • Prequel®
        • Precise Tumor®
        • Prolaris®
        • SneakPeek®
  • About
    • About
      • (column wrapper)
        • About Myriad
        • Leadership
        • Investor relations
      • (column wrapper)
        • Press releases
        • Careers
        • Contact
    • (sidebar parent)
      • Myriad Genetics Laboratory and Support Center
        • 322 North 2200 West
        • Salt Lake City, UT 84116
        • Corporate Phone: (801) 584-3600
        • Corporate Fax: (801) 584-3640
PORTALS ORDER
    Portals
    Order
  • Patients
    • I need help with…
      • Understanding hereditary cancer riskWhat is my risk of developing hereditary cancer?
      • Treating cancerWhat are my treatment options?
      • Guiding prenatal careAm I having a boy or girl?
        • Is my baby at risk for a genetic condition?
      • Managing mental healthHow might my genes affect my medication outcomes?
    • (sidebar parent)
      • About genetic testing
        • Affordability
        • Financial assistance
      • Patient Resources
        • How does genetic testing work?
        • Patient record request
        • Blood draw locator
        • Blog
      • Prostate Cancer
        • What are my treatment options?
  • Providers
    • My patient needs a test for…
      • Assessing hereditary cancer riskWhat is my patient’s risk of developing hereditary cancer?
      • Cancer treatmentWhat is the best treatment for my patient?
      • Prenatal careWhat is the predicted fetal sex of my patient’s baby?
        • What is a pregnancy’s risk of a genetic disease?
      • Mental health treatmentHow will my patient metabolize or respond to certain medications?
    • (sidebar parent)
      • About our tests
        • Myriad test catalog
        • Scientific Publications
        • MyRisk® gene table
        • Affordability
        • Financial assistance
        • EMR Integrations
      • Provider resources
        • Order a test kit
        • Order patient materials
        • Documents & forms
        • Scope of service & lab certificates
        • Provider portal
        • Blood draw locator
        • Blog
      • Prostate Cancer Treatment
        • What are my patient’s treatment options?
  • Biopharma
  • Our Tests
    • Tests for…
      • (column wrapper)
        • Prenatal care
          • Fetal sex
          • Chromosome conditions
          • Genetic diseases
        • Cancer risk assessment
          • Hereditary cancer
        • Mental health
          • Depression
          • Anxiety
          • ADHD
      • (column wrapper)
        • Cancer management
          • Breast cancer
          • Ovarian cancer
          • Pancreatic cancer
          • Prostate cancer
          • Endometrial cancer
          • Other cancers
          • All tests
    • (sidebar parent)
      • TESTS BY SPECIALTY
        • Oncology
        • Urology
        • Imaging
        • OB/GYN
        • Mental Health
        • Internal/Primary care
        • All tests
      • TESTS BY NAME
        • BRACAnalysis CDx®
        • EndoPredict®
        • Foresight®
        • GeneSight®
        • MyChoice® CDx
        • MyRisk® (cancer treatment)
        • MyRisk® (cancer risk)
        • Prequel®
        • Precise Tumor®
        • Prolaris®
        • SneakPeek®
  • About
    • About
      • (column wrapper)
        • About Myriad
        • Leadership
        • Investor relations
      • (column wrapper)
        • Press releases
        • Careers
        • Contact
    • (sidebar parent)
      • Myriad Genetics Laboratory and Support Center
        • 322 North 2200 West
        • Salt Lake City, UT 84116
        • Corporate Phone: (801) 584-3600
        • Corporate Fax: (801) 584-3640

Category: Ovarian Cancer

Ovarian Cancer > Page 2
  • Category
    • All
    • About Myriad Genetics
    • Breast Cancer
    • Carrier screening
    • Colorectal Cancer
    • Corporate
    • Diversity
    • Employee Spotlight
    • EndoPredict
    • Equity
    • GeneSight
    • Genetic Counselors
    • Gynecologic Cancer
    • Hereditary Cancer
    • Inclusion
    • Infographic for Multimedia page
    • Infographics
    • Lynch Syndrome
    • Melanoma
    • Myriad Employees
    • Myriad Science and Facilities
    • MyRisk
    • Neuroscience
    • Ovarian Cancer
    • Pancreatic Cancer
    • Patient Blog
    • Patient Story
    • Patient-Featured
    • Prenatal care
    • Prenatal Screening (NIPS)
    • Prequel
    • Prolaris
    • Prostate Cancer
    • Provider Blog
    • Uncategorized
    • Urology
    • Women's Health

Today is World Ovarian Cancer Day

May 8, 2013

Today, May 8th 2013 marks the very first World Ovarian Cancer Day. Today several organizations from around the world will join forces to raise awareness about o...

Continue Reading

Myriad Genetics, the Supreme Court, Gene Patents, and Saving Lives

April 11, 2013

We’re in the business of saving lives.  That’s what really matters to me, and to the very bright people who work with me at Myriad. We offer testing for pa...

Continue Reading

How have you celebrated Cancer Prevention Awareness Month?

February 25, 2013

As the shortest month of the year draws to a close, it’s important to remember that it takes longer than 28 days to prevent the impact of cancer on your life...

Continue Reading

What are the guidelines for surveillance for a BRCA-positive patient who has undergone prophylactic mastectomy and salpingo-oophorectomy?

January 11, 2013

There are limited recommendations on this topic.1 The following summarizes the literature, however, a clinician’s judgment will also be based on the patient�...

Continue Reading

Cancer Wellness House Holiday Party

December 21, 2012

The holidays are known as a time for giving and Myriad proudly helped bring that giving spirit to the Cancer Wellness House’s annual holiday party.  T...

Continue Reading

Learn Your Family’s Medical History During The Holidays

November 21, 2012

It’s that time of year again! We want to remind you that during all of these family holiday gatherings it is a great time to talk to your family members abou...

Continue Reading

Introducing the Hereditary Cancer Quiz!

November 16, 2012

Myriad is excited to announce the launch of the online Hereditary Cancer Quiz. This quiz was designed for the general public as an easy to use, online quiz th...

Continue Reading

ACOG District II show in New York

November 15, 2012

The Preventive Care marketing team had the opportunity to attend the ACOG District II show in New York a few weeks ago. This year Myriad had a presentation abou...

Continue Reading

Imagine the Impact – NOCC Conference 2012

November 14, 2012

The National Ovarian Cancer Coalition (NOCC)’s 2012 Conference in Las Vegas, Nevada was held November 8th through 10th. Survivors, caregivers, healthcare prof...

Continue Reading

Walk to Break the Silence on Ovarian Cancer – National Ovarian Cancer Coalition (NOCC)

November 1, 2012

This fall Myriad participated in eleven National Ovarian Cancer Coalition Walks to Break the Silence on Ovarian Cancer with just one more walk to go in San Ant...

Continue Reading

Turkey Dinner, Christmas Shopping, A Wedding and…HBOC?

October 8, 2012

Leslie had everything planned for her upcoming Thanksgiving feast. Her Christmas shopping lists were in order, and she was ready to host the rehearsal party fo...

Continue Reading

September 26 is National Previvor Day

September 26, 2012

September 26, 2012 is National Previvor Day. At Myriad, we believe knowledge is power, and Previvors embody this sentiment. A Previvor refers to an individual ...

Continue Reading

National HBOC Week and National Previvor Day

September 24, 2012

In 2010, Congress passed a resolution declaring the last week of September as National Hereditary Breast and Ovarian Cancer (HBOC) Week (September 23–30, 2012...

Continue Reading
  • 1
  • 2
  • Managed care
    • Payers
  • Investors
    • Investor relations
  • News
    • Press releases
    • Blog
  • About
    • About Myriad
    • Careers
    • Contact us
  • Terms of Use
  • Your Privacy Choices
  • Provider Portal Terms of Use
  • HIPAA Notice of Privacy Practices
  • Patents
  • Privacy Notice
  • Compliance and Code of Conduct
  • Health Privacy Notice
  • Notice of Nondiscrimination and Discrimination Grievance Procedure
  • Cookie Notice
  • Notice of Access to Language Assistance Services
  • IT Security
  • Cookie Preferences
facebook linkedin x X/Twitter social network instagram youtube
  • © 2025 Myriad Genetics, Inc.

Locations

United States
Europe
Japan